Reuters logo
a year ago
BRIEF-Elanco Animal Health enters agreement to acquire Boehringer Ingelheim Vetmedica's U.S. feline, canine and rabies vaccines portfolio
October 5, 2016 / 11:01 AM / a year ago

BRIEF-Elanco Animal Health enters agreement to acquire Boehringer Ingelheim Vetmedica's U.S. feline, canine and rabies vaccines portfolio

Oct 5 (Reuters) - Eli Lilly And Co

* Elanco Animal Health enters agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. feline, canine and rabies vaccines portfolio

* Deal for $885 million

* Lilly expects acquisition to be accretive to GAAP earnings in 2019 and to non-GAAP earnings in 2018

* Acquisition is anticipated to close by early 2017, subject to approval by Federal Trade Commission

* Also included in agreement are several pipeline assets Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below